Danielle Collins
Physician Assistant · Centennial, CONPI 1255983888
Payments from drug & device makers
Across 55 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$196
- AstraZeneca$135
- Novo Nordisk$103
- Otsuka America Pharmaceutical, Inc.$94
- Philips North America LLC$87
- Exact Sciences$72
- plus $546 from 15 others
What the payments were for
- Food & beverage$1,233100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 10 | $196 |
| AstraZeneca | 6 | $135 |
| Novo Nordisk | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Philips North America LLC | 3 | $87 |
| Exact Sciences | 4 | $72 |
| Lilly USA, LLC | 4 | $66 |
| BETA Bionics, Inc. | 2 | $57 |
| Edwards Lifesciences | 2 | $55 |
| GSK | 2 | $48 |
| Merck | 2 | $45 |
| Abiomed | 1 | $43 |
| Cleerly, Inc. | 1 | $35 |
| Astellas Pharma US Inc | 1 | $32 |
| Abbott | 1 | $30 |
| Seqirus USA Inc | 1 | $29 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Johnson & Johnson | 1 | $21 |
| Bayer | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
How this compares
$1,233 in reported general payments places this provider in the 75th percentile of 2,849 physician assistant providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 38 | $60,778 |
| OzempicSemaglutide | 21 | $38,903 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $38,532 |
| TrulicityDulaglutide | 20 | $28,538 |
| XareltoRivaroxaban | 17 | $25,577 |
| FarxigaDapagliflozin Propanediol | 13 | $19,352 |
| MounjaroTirzepatide | 14 | $15,616 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 27 | $3,661 |
| Gabapentin | 71 | $2,208 |
| SynthroidLevothyroxine Sodium | 20 | $1,921 |
| Omeprazole | 69 | $1,881 |
| Atorvastatin Calcium | 178 | $1,693 |
| Levothyroxine Sodium | 156 | $1,482 |
| Tamsulosin Hcl | 61 | $783 |
| Losartan Potassium | 107 | $779 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $196 | $60,77838 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $66 | $44,15434 claims |
| Novo NordiskOzempic | $103 | $38,90321 claims |
| GSKTrelegy Ellipta | $48 | $38,53230 claims |
| Johnson & JohnsonXarelto | $21 | $25,57717 claims |
| AstraZenecaFarxiga | $135 | $19,35213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Centennial
- Hillary ChingCentennial$35K
- Rachelle WebsterCentennial$18K
- Yury GadayevCentennial$18K
- Melissa ButlerCentennial$12K
- Jordan BeckerCentennial$10K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.